| Authors: |
Adams HP; Signature Diagnostics GmbH, Potsdam, Germany., Hiemenz MC; Foundation Medicine, Inc., Cambridge, Massachusetts., Hertel K; Helios MVZ Pathologie Erfurt GmbH, Erfurt, Germany., Fuhlbrück F; Signature Diagnostics GmbH, Potsdam, Germany., Thomas M; F. Hoffmann-La Roche AG, Basel, Switzerland., Oughton J; Foundation Medicine, Inc., Cambridge, Massachusetts., Sorensen H; Roche Diagnostics Solutions, Inc., Santa Clara, California., Schlecht U; Signature Diagnostics GmbH, Potsdam, Germany., Allen JM; Foundation Medicine, Inc., Cambridge, Massachusetts., Cantone M; Lab Operations, Foundation Medicine GmbH, Penzberg, Germany., Osswald S; Lab Operations, Foundation Medicine GmbH, Penzberg, Germany., Gonzalez D; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, United Kingdom., Pikarsky E; The Lautenberg Center for Immunology, Institute for Medical Research Israel-Canada, Hebrew University-Hadassah Medical School, Jerusalem, Israel., De Vos M; Roche Diagnostics Solutions, Rotkreuz, Switzerland., Schuuring E; Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Wieland T; Lab Operations, Foundation Medicine GmbH, Penzberg, Germany. Electronic address: twieland@foundationmedicine.com. |
